Testmate Health SA

Low-cost accurate molecular tests from point-of-care to home

Testmate Health has microengineered the power of a PCR machine into a low-cost, single-use disposable, test that can detect any DNA or RNA sequence with immediate results from the point-of-care to at-home. Our technological platform has proven lab equivalent accuracy even in challenging samples like urine.

Our first product addresses the $14B sexual health & women's health market, with the first disposable urine test that can detect chlamydia & gonorrhoea in all genders. Built for automated high scaled manufacturing, low COGs & high usability, Testmate addresses the rising silent epidemic of sexually transmitted infections, in a product format & price point that is finally compatible with the public health programs that are urgently tackling this problem.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

24.05.2024

31st Prix Strategis crowns HeroSupport (startupticker.ch)

03.05.2024

USD 6 million to fight a silent epidemic (startupticker.ch)

Deal

01.06.2023

Completion of lab validation studies

Deal

30.04.2023

Completion of 1st stage human factors testing

Milestone

21.09.2021

Closing of seed round

Deal

01.06.2021

Testmate Health kicks off at Biôpole

No Jobs

Videos

De Vigier Winner 2021

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

UNIGE Spin-off

Website

Venture Leaders Medtech

Testmate Health SA

Low-cost accurate molecular tests from point-of-care to home

Headquarter:
Epalinges

Foundation Date:
April 2020

Technology:

  • Medtech

Sectors:

  • Digital Health
  • Diagnostics
  • Medical devices
  • Medtech

Support received

  • Support venture leaders
  • Support venturekick
  • Support TOP 100